Cost of clinical trials, 2007. http://deepfreeze9.blogspot. com/2007/07/factoids-cost-of-clinical-trials.html. Updated 2007. Accessed September 16, 2007.Fee R: The cost of clinical trials. Drug Discov Dev 2007, 10:32....
Skip to main contentSkip to article Journals & Books
He continues to research alternative therapies for various medical conditions, and with IRB certified clinical trials, has treated local and international patients for Multiple Sclerosis (MS), Chronic Low Grade Inflammation (which is part of the overall Aging Process), and many other degenerative condi...
A cost-evaluation model was applied to clinical trial protocols to estimate their cost for the hospital pharmacy service. The steps taken in the drug management of clinical research were identified. Fixed costs (common to all clinical trials) and variable costs (peculiar to each clinical trial) ...
Parkinson’s disease, Multiple Sclerosis (MS), bipolar and schizophrenia. Historically, CNS drugs have had failure rates in clinical trials. Recent advancements have introduced a wave of innovative drugs. While these advancements hold promise for improving patient outcomes, they may bring cost challenge...
Fractional flow reserve–guided PCI should be considered in determining the treatment strategy for non-IRA stenoses in these patients. Trial Registration ClinicalTrials.gov Identifier: NCT02715518 Introduction Previous randomized clinical trials and registry data have shown that percutaneous coronary ...
This study assesses the cost-effectiveness of electroconvulsive therapy compared with pharmacotherapy/psychotherapy for treatment-resistant major
In this study, we propose a multi-objective clinical site selection model that considers the trade-off between time and cost of clinical trials. An efficiency curve representing the Pareto-optimal trade-off is provided for decision makers to design the supply chain. To identify all Pareto-optimal...
3.4.1.Amendments as regards the clinical trials protocol 119. With regard to the protocol, the following is a non- exhaustive list of amendments that are typically ‘substantial’: (a) change of main objective of the c...
X.-Y. Yang, L.-Q. Wang, J.-G. Li, N. Liang, Y. Wang, and J.-P. Liu, “Chinese herbal medicine Dengzhan Shengmai capsule as adjunctive treatment for ischemic stroke: a systematic review and meta-analysis of randomized clinical trials,”Complementary Therapies in Medicine, vol. 36, ...